Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China flag China · Delayed Price · Currency is CNY
22.19
-0.43 (-1.90%)
May 12, 2026, 3:00 PM CST

Aurisco Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,95210,1758,57910,48810,0298,830
Market Cap Growth
12.78%18.61%-18.20%4.58%13.58%38.75%
Enterprise Value
9,02810,1268,31710,0569,7268,296
Last Close Price
22.1925.0520.8225.2123.9621.25
PE Ratio
23.0422.6524.1836.2447.5452.34
Forward PE
16.3216.7318.6930.4739.82-
PS Ratio
5.315.995.818.319.9510.99
PB Ratio
3.293.833.685.335.965.86
P/TBV Ratio
3.504.083.955.686.466.02
P/FCF Ratio
67.67142.46-130.89--
P/OCF Ratio
18.4924.1425.8127.2060.2743.81
EV/Sales Ratio
5.365.975.647.979.6510.33
EV/EBITDA Ratio
14.7015.5317.7328.4935.6135.42
EV/EBIT Ratio
18.8519.0121.5336.0746.7145.40
EV/FCF Ratio
68.25141.77-125.50--
Debt / Equity Ratio
0.370.360.410.060.030.01
Debt / EBITDA Ratio
1.621.462.000.330.190.08
Debt / FCF Ratio
7.5113.43-1.46--
Net Debt / Equity Ratio
0.030.00-0.05-0.22-0.20-0.28
Net Debt / EBITDA Ratio
0.130.01-0.26-1.22-1.24-1.82
Net Debt / FCF Ratio
0.580.070.58-5.356.818.70
Asset Turnover
0.410.420.460.550.540.49
Inventory Turnover
1.131.131.151.181.281.45
Quick Ratio
2.802.672.681.691.923.06
Current Ratio
4.223.953.852.733.384.87
Return on Equity (ROE)
15.26%18.01%16.50%15.83%13.05%11.63%
Return on Assets (ROA)
7.35%8.22%7.49%7.56%6.93%7.02%
Return on Invested Capital (ROIC)
15.23%18.95%17.95%16.99%14.85%16.68%
Return on Capital Employed (ROCE)
12.70%14.40%11.60%13.40%12.20%12.00%
Earnings Yield
4.40%4.42%4.14%2.76%2.10%1.91%
FCF Yield
1.48%0.70%-2.42%0.76%-0.50%-0.56%
Dividend Yield
1.50%1.36%1.39%0.87%0.67%0.61%
Payout Ratio
31.50%27.63%26.72%23.15%24.81%28.52%
Buyback Yield / Dilution
-3.37%-2.44%2.21%-0.48%-1.00%-7.31%
Total Shareholder Return
-1.88%-1.08%3.60%0.40%-0.33%-6.69%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.